Drug Database
Back to search

Iceland· IS-EU/1/22/1669/001

Pepaxti

A melphalan flufenamide product containing melphalanum inn hýdróklóríð, registered in Iceland by Oncopeptides AB. The same ATC class is registered in 8 of our 19 countries.

ATC L01AA10

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedPepaxtiATCL01AA10REGISTER NO.IS-EU/1/22/1669/001PACKS LISTED0CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about melphalanum inn hýdróklóríðAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Melphalan flufenamide is registered in 8 of 19 countries.

Countries holding a registration under ATC L01AA10 (melphalan flufenamide), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 5 of them publish a price we can compare per daily dose
Search melphalan flufenamide products by name

Melphalan flufenamide · ATC L01AA10

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Melphalanum INN hýdróklóríð
Manufacturer
Oncopeptides AB
Country
Iceland (IS)
ATC code
L01AA10
ATC class
Melphalan flufenamide
Defined daily dose
1.4 mg, P
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for melphalan flufenamide.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check melphalan flufenamide against other medicinesHow interaction checks work

Melphalan flufenamide · interactions on record

10 records

  • 4 moderate
  • 6 minor

Most severe, free to view

  • IfosfamideL01AA06moderate
  • DacarbazineL01AX04moderate
  • CytarabineL01BC01moderate
  • VinblastineL01CA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Melphalan flufenamide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All melphalan flufenamide products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Alkeran, Melphalan Hikma
  • Belgium · Alkeran, Melfalan Tillomed
  • Cyprus · Melfalan Tillomed
  • Czechia · Alkeran, Melphalan Zentiva
  • Germany · Alkeran, Melphalan
  • Denmark · Alkeran, Melphalan Macure
  • Estonia · Alkeran
  • Spain · Alkeran, Melfalán Aspen
  • Finland · Alkeran, Melphalan Macure
  • France · Alkeran, Melphalan Hikma
  • United Kingdom (Northern Ireland) · Melphalan, Melphalan Accord-Uk
  • Greece · Demephan, Melphalan Tillomed
  • Croatia · Melfalan Pliva, Melfalan Tillomed
  • Hungary · Melphalan Teva, Melphalan Zentiva
  • Ireland · Alkeran, Melphalan Tillomed
  • Italy · Alkeran, Melfalan Hikma
  • Liechtenstein · Phelinun
  • Lithuania · Alkeran, Melphalan Zentiva
  • Luxembourg · Alkeran, Melphalan Aqvida
  • Latvia · Alkeran, Melphalan Tillomed
  • Netherlands · Alkeran, Melfalan Amarox
  • Norway · Alkeran, Melphalan Macure
  • Poland · Alkeran, Melphalan Zentiva
  • Portugal · Alkeran, Melfalano Eugia
  • Romania · Alkeran, Melfalan Teva
  • Sweden · Alkeran, Melfalan Sun
  • Slovenia · Alkeran, Melfalan Teva
  • Slovakia · Alkeran, Melphalan Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d83a9315-c7a9-4734-830f-ff0ee2da1fe9
GET /v1/drugs/d83a9315-c7a9-4734-830f-ff0ee2da1fe9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stofn fyrir innrennslisþykkni, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "L01AA10",
  "marketed": false,
  "strength": "20 mg",
  "ma_number": "EU/1/22/1669/001",
  "substance": "Melphalanum INN hýdróklóríð",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
  "ma_issued_serial": "44790"
}
API referenceMCP serverPlans

See everything about melphalan flufenamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console